Paglalarawan

The microbiome is the natural bacterial colonisation of the body – including skin, gut and stomach. The human microbiome refers to the spectrum of microbes (microbiota) that colonize humans. Microbiome therapies are currently focused on the prevention of C. difficile recurrence. This bacterium is often contracted in hospitals following antibiotic administration or a period of immunosuppression. The global microbiome therapeutics market is set to grow by US$ 918 million during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 32.5% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix. Significant external funding for executing research and therapeutic innovation, increasing adoption of inorganic growth strategies in the market, growing demand for novel therapies to address the unmet needs of many diseases are expected to boost the market growth in the coming years.

Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2017-2020 at forecast na 2027 covering key market aspects like sales value for microbiome therapeutics. The global microbiome therapeutics market is segmented on the basis of target therapy area, rehiyon. By target therapy area, it is categorized into gastrointestinal diseases, infections, at iba pa. The gastrointestinal diseases segment held the largest market share in 2020. By region, the microbiome therapeutics market is divided into North America, Asya Pasipiko, Europa, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as 4D Pharma plc, AOBiome Therapeutics Inc., Assembly Biosciences Inc., Eligo Bioscience S.A.S, Finch Therapeutics Group Inc., MaaT Pharma SA, Quorum Innovations LLC, Rebiotix Inc. (Ferring Pharmaceuticals Group), Seres Therapeutics Inc., Synthetic Biologics, Vedanta Biosciences Inc..

Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the microbiome therapeutics market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

Saklaw ng Ulat

Target therapy area: gastrointestinal diseases, infections, at iba pa
Rehiyon: Hilagang Amerika, Asya Pasipiko, Europa, and Rest of the World (ROW)
Mga Taon na Itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2017 sa 2027

Mga Pangunahing Benepisyo para sa mga Stakeholder

Get a comprehensive picture of the global microbiome therapeutics market
Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan
Understand what the future of the global microbiome therapeutics market looks like
Kilalanin ang mapagkumpitensya na landscape at window ng pagkakataon

Talaan ng mga Nilalaman

1. Kahulugan ng Market
2. Metodolohiya ng Pananaliksik
3. Market Data & Outlook
3.1 Halaga ng Market
3.2 Pagtataya ng Halaga sa Market
4. Microbiome Therapeutics Market by Target Therapy Area
4.1 Gastrointestinal Diseases
4.2 Infections
4.3 Ang iba naman
5. Microbiome Therapeutics Market by Region
5.1 Hilagang Amerika
5.2 Asya Pasipiko
5.3 Europa
5.4 Rest Of The World (Row)
6. Mga Profile ng Kumpanya
6.1 4D Pharma plc
6.2 AOBiome Therapeutics, Inc.
6.3 Assembly Biosciences, Inc.
6.4 Eligo Bioscience S.A.S
6.5 Finch Therapeutics Group, Inc.
6.6 MaaT Pharma SA
6.7 Quorum Innovations, LLC
6.8 Rebiotix, Inc. (Ferring Pharmaceuticals Group)
6.9 Seres Therapeutics, Inc.
6.10 Synthetic Biologics
6.11 Vedanta Biosciences, Inc.
7. Apendiks
7.1 Tungkol sa StrategyHelix
7.2 Pagtanggi